Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Opiant Pharmaceuticals Inc (OTCQB:OPNT)

7.71
Delayed Data
As of Jul 26
 -0.495 / -6.04%
Today’s Change
6.00
Today|||52-Week Range
14.00
-21.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.001.6M
 
 
Depreciation And Amortization1.4K1.4K1.4K1.4K
 
 
 
 
 
 
Operating ExpensesGross Income-1.4K-1.4K-1.4K--
 
 
 
 
General Expenses12.3M4.3M11.3M8.4M
 
 
 
 
 
Research And Development506.2K282.7K464.6K2.4M
 
 
 
 
 
Total Operating Expenses12.3M4.3M11.3M8.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.3M-4.3M-11.3M-6.9M
 
 
 
 
 
Extraordinary Credit0.00182.1K20.7K0.00
 
 
 
Extraordinary Charge-24.1K0.00-27.1K0.00
 
 
 
Interest Expense On Debt61.4K553.0K160.3K28.2K
 
 
 
 
 
Other Expenses0.000.00-12.7K-110.1K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.4M-4.7M-11.5M-7.0M
 
 
 
 
 
Net Income-12.4M-4.7M-11.5M-7.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.0M1.4M1.7M4.0M
 
 
 
 
 
Shares To Calculate EPS Diluted--1.4M1.7M4.0M
 
 
 
 
 
Earnings Per ShareEPS---$3.00-$7.00-$3.88
 
 
 
 
EPS Diluted-$11.96-$3.00-$7.00-$1.75